Unicoat Pharma ApS: Financial statements 2024
CVR: 37166707
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Unicoat Pharma ApS (CVR 37166707) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 801,870 and a net result of DKK 638,057 compared with DKK 777,379 the year before. That is a decrease of 18.8% compared with the year before. Equity in the 2024 report amounted to DKK 288,060. The solvency ratio was 54.1%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 801,870
- Profit/Loss
- DKK 638,057
- Equity
- DKK 288,060
- Total Assets
- DKK 532,881
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 802 t. | 638 t. | 288 t. | 3 |
| 2023 | - | 988 t. | 777 t. | 577 t. | - |
| 2022 | - | 705 t. | 542 t. | 393 t. | - |
| 2021 | - | 689 t. | 535 t. | 290 t. | - |
| 2020 | - | 1.3 mio. | 632 t. | 144 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of October 8, 2024, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Unicoat Pharma ApS.
As of October 8, 2024, DP Hillerød P/S has stepped down as auditor of Unicoat Pharma ApS.
Unicoat Pharma ApS has published its annual report for 2023. Gross profit came to DKK 987,760, and the net result was DKK 777,379.
About Unicoat Pharma ApS
Unicoat Pharma ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2015. The company is registered under the industry Overfladebehandling af metal. The management consists of Morten Clausen, Amanda Ryberg and Magnus Knorr Clausen. The company is owned by M C Holding ApS, MCVA Holding ApS and A Ryberg Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 867,952 and a net result of DKK 680,181 compared with DKK 638,057 the year before. Equity in the 2025 report amounted to DKK 507,241.